Kriya Therapeutics Funding & Investors
Palo Alto, CA
Kriya Therapeutics is a transformative gene therapy company with the intent to expand gene therapy to broader disease indications leveraging in house manufacturing capabilities and novel therapeutic designs.
kriyatherapeutics.comTotal Amount Raised: $600,499,968
Kriya Therapeutics Funding Rounds
Series C
$150,000,000
Series C Investors
Patient Square CapitalSeries C
$270,000,000
Series C Investors
Patient Square CapitalForesite CapitalDEXCEL-PHARMATranshuman CapitalQVT FinancialJDRF T1D FundBluebird VenturesNarya CapitalCAM CapitalLightswitch CapitalAlumni Ventures GroupSeries B
$100,000,000
Series B Investors
Patient Square CapitalWoodline PartnersDEXCEL-PHARMACAM CapitalNarya CapitalAmploTranshuman CapitalBluebird VenturesHongkouAlumni Ventures GroupQVT FinancialJDRF T1D FundForesite CapitalSeries A
$80,500,000
Series A Investors
QVT FinancialForesite CapitalNarya CapitalPaul ManningAmploTranshuman CapitalBluebird VenturesDEXCEL-PHARMAJDRF T1D FundSahsen Ventures
Funding info provided by Diffbot.